Christopher T Chen

8PUBLICATIONS
85CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 20, 2025
p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program.

Mengxiong Wang, Kathryn T Bieging-Rolett, Alyssa M Kaiser

|Sep 11, 2025
Immunotherapy Efficacy in Mismatch Repair-Proficient Colorectal Cancer Patients With and Without Liver Metastases.

Evan R Beiter, Shruti R Patel, Christopher T Chen

|Aug 11, 2025
Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results.

Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder

|Oct 25, 2024
Redefining Available Therapy in Oncology Accelerated Approval Decisions.

Shruti Rajesh Patel, Maya Ramachandran, Angela Ai

|Aug 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.

Christopher T Chen, Vishesh Khanna, Shivaani Kummar

|Jun 10, 2024
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship.

Timil Patel, Chris Chen, Samer Al Hadidi

Pageof 2